Remove 2020 Remove Omnicell Remove Pharmaceutical Companies
article thumbnail

The History and Noble Purpose of the 340B Drug Pricing Program

Omnicell

Ken Perez Vice President of Healthcare Policy, Omnicell; In Sept. 2020, the U.S. Please visit Omnicell's Webinars to learn more about 340B and other healthcare topics. Add link to Omnicell's Webinars. Census Bureau announced that the number of Americans in poverty in 2019 was 34 million, about 10.5

article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceutical companies to publish their prices in a password protected site on HRSA's website. 2020: After being sued once again by 340B providers, HRSA established the Administrative Dispute Resolution program.

article thumbnail

Congress Continues to Display Strong Bipartisan Support for the 340B Drug Pricing Program

Omnicell

Pharma’s Challenges to 340B During July and August, several large pharmaceutical companies challenged the operation of the 340B program. John Thune (R-S.D.), Debbie Stabenow (D-Mich.), Rob Portman (R-Ohio), Tammy Baldwin (D-Wis.), and Ben Cardin (D-Md.),